Clinical Pharmacology: Current Topics and Case Studies

Today we witness an eventful time in which the powerful new forces of genomics, information technology and economics are rapidly changing the science and art of medicine. This will require more specialization than ever before. However, there is also an increasing demand for an integrated approach, w...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Müller, Markus (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Vienna : Springer Vienna, 2010.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • The discipline of Clinical Pharmacology
  • Current issues in drug development
  • Current issues in drug regulation
  • Current issues in drug reimbursement
  • Clinical Trials
  • Ethics in clinical research
  • Good Clinical Practice (GCP) and scientific misconduct
  • Phase-I studies and first-in-human trials
  • Clinical trials - interventional studies
  • Observational studies
  • Pharmacokinetics I: PK-PD approaches - antibiotic drug development
  • Pharmacokinetics II: 14C-labelled microdosing in assessing drug pharmacokinetics at Phase-0
  • Epidemiology and bio statistics
  • Placebo effects and placebo control in clinical trials
  • Tools in Clinical Pharmacology
  • Tools in clinical pharmacology - imaging techniques
  • Current concepts of pharmacogenetics, pharmacogenomics, and the “druggable” genome
  • Biomarkers
  • Molecular tools in drug research — translational medicine
  • Topics in Clinical Pharmacology
  • Pharmaceutical drug safety
  • Drug interactions medicine
  • “Non-chemical” drugs: biologicals, protein therapeutics, vaccines and antisense therapeutics
  • Development of Advanced Therapy Medicinal Products — a case for early scientific advice
  • Individualized medicine
  • Generics, biosimilars, enantiomers and me-toos
  • Special situations, market fragmentation I: orphan drugs for rare diseases
  • Special situations, market fragmentation II: sex differences
  • Special situations III: Medicines for Children.